Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions

Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions

BACKGROUND AND AIMS Direct-acting antiviral agents have revolutionised hepatitis C treatment. In 2014, the Swiss Hepatitis Strategy was developed to eliminate hepatitis C virus (HCV) infection and the associated liver-related morbidity and mortality by 2030. Though numerous national stud...

Full description

Bibliographic Details
Main Authors: Urs Rusch, Sarah Robbins, Homie Razavi, Pietro Vernazza, Sarah Blach, Philip Bruggmann, Beat Müllhaupt, Francesco Negro, David Semela
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2019-01-01
Series:Swiss Medical Weekly
Subjects:
hepatitis C virus
hepatocellular carcinoma
liver cirrhosis
Switzerland
Online Access:https://www.smw.ch/index.php/smw/article/view/2569

Internet

https://www.smw.ch/index.php/smw/article/view/2569

Similar Items